NUVO PHARMACEUTICALS ORDINARY SHARES (NRIFF) SI Increased By 1540%

A report by Jan Rainey published on April 29th 2018, suggests that NUVO PHARMACEUTICALS INC ORDINARY SHARES (OTCMKTS: NRIFF) had an increase of 1540% in short interest.

Among the products NUVO offers is Resultz, an over-the-counter product, intended to kill head lice and remove their eggs from hair. This report revealed that NRIFF’s SI was 8,200 shares in April as released by FINRA. It is up 1540% from 500 shares previously. Nuvo Pharmaceuticals Inc.

Novo Pharmaceuticals is a commercial healthcare company which produces and sells pharmaceutical products in the United States, Canada, and Europe. The company has market cap of $27.51 million. The firm was formerly known as Nuvo Research Inc. and changed its name to Nuvo Pharmaceuticals Inc. in March 2016.